NCT00165763View on ClinicalTrials.gov

Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2009

Conditions
Vascular Dementia
Interventions
DRUG

donepezil hydrochloride (Aricept)

5 mg donepezil HCl given once a day and increased to 10 mg per day if side effects, when present, are tolerated.

Trial Locations (2)

Unknown

Memory Center, Quezon

Subic Bay Medical Center, Olongapo City

All Listed Sponsors
collaborator

Eisai Co., Ltd.

INDUSTRY

lead

Eisai Inc.

INDUSTRY

NCT00165763 - Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia | Biotech Hunter | Biotech Hunter